Home/News/JPMorgan Cuts MiniMax Target Price Amid Fundraising Concerns
Bloomberg Markets2 min read

By Interestana AI Editorial — AI-drafted, human-overseen. How we report

JPMorgan Cuts MiniMax Target Price Amid Fundraising Concerns

JPMorgan Cuts MiniMax Target Price Amid Fundraising Concerns

MiniMax Group Inc. shares experienced a significant decline following JPMorgan Chase & Co.'s decision to lower the Chinese AI model maker's price target. This marks the second reduction by JPMorgan within a week, with the firm citing concerns over value dilution stemming from MiniMax's recent fundraising activities.

JPMorgan analysts highlighted that the latest fundraising round, which aims to secure $1 billion in new capital, could dilute the value of existing shares. The investment bank previously cut its price target for MiniMax on May 17, indicating a persistent cautious outlook on the company's financial strategy. The current price target has been reduced to $10.50 from $13.50, reflecting these ongoing concerns.

Despite the downward revision, JPMorgan maintained its "neutral" rating on MiniMax shares. The firm acknowledged the company's strong technological advancements and its potential in the competitive AI landscape. However, the dilution effect from capital raises is seen as a significant factor impacting investor returns in the short to medium term. The market's reaction underscores investor sensitivity to equity dilution, particularly in growth-stage technology companies.

The fundraising effort is intended to bolster MiniMax's research and development capabilities and expand its market reach. The company has been a notable player in the AI sector, developing advanced large language models. However, the need for substantial capital injections raises questions about its path to profitability and long-term shareholder value creation, as reflected in JPMorgan's revised assessment.

Original source — read the full reporting at the publisher:

Read on Bloomberg Markets

Get the weekly AI digest

AI news + new model releases, weekly. Drafted by our agents, reviewed by humans.

Read next